SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363763-17-000005
Filing Date
2017-01-20
Accepted
2017-01-20 21:24:38
Documents
1
Period of Report
2017-01-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 8870
  Complete submission text file 0001363763-17-000005.txt   10369
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLIQUA, INC. 850 THIRD AVENUE, SUITE 1801 NEW YORK NY 10022
Business Address
SAPIRSTEIN JAMES (Reporting) CIK: 0001559509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 17539730